D-0312-2025 Class III Ongoing

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0312-2025 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Mar 4, 2025 and is designated Class III. Reason for recall: Cross Contamination The recall status is ongoing. Affected quantity: 852 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 16, 2025
Initiation Date
Mar 4, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
852 bottles

Product description

Gabapentin Capsules, USP 400 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-139-05; b) 1000-count bottles, NDC 62756-139-04; Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India.

Reason for recall

Cross Contamination

Distribution pattern

Nationwide in the USA

Code information

Lot # a) HAD1712B, Exp. date 03/2025 b) HAD1712C, exp. date 03/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0312-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0312-2025. Report a data issue: hello@regdatalab.com.